¸é¿ªÁ¾¾çÇÐ ºÐ¼® ½ÃÀå : Á¦Ç°º°, ±â¼úº°, ÀûÀÀÁõº°, ¿ëµµº°, Áö¿ªº°
Immuno-Oncology Assays Market, By Product, By Technology, By Indication, By Application, By Geography
»óǰÄÚµå : 1672961
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,511,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,000 £Ü 10,128,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 14,469,000
PDF (Enterprise User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¸é¿ªÁ¾¾çÇÐ ºÐ¼® ¼¼°è ½ÃÀåÀº 2025³â¿¡´Â 55¾ï 5,000¸¸ ´Þ·¯, 2032³â¿¡´Â 118¾ï 2,000¸¸ ´Þ·¯¿¡ À̸£°í, 2025-2032³â CAGR 11.4%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ ¼¼ºÎÁ¤º¸
±âÁØ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 55¾ï 5,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£(2025-2032³â) CAGR 11.40% 2032³â °¡Ä¡ ¿¹Ãø 118¾ï 2,000¸¸ ´Þ·¯
±×¸². ¸é¿ªÁ¾¾çÇÐ ºÐ¼® ½ÃÀå Á¡À¯À²(%), 2025³âÁö¿ªº°
Immuno-Oncology Assays Market-IMG1

¸é¿ªÁ¾¾çÇÐ ºÐ¼®Àº ¾Ï ¸é¿ª ¿ä¹ý°ú °ü·ÃµÈ ´Ü¹éÁú°ú °°Àº »ýü ºÐÀÚÀÇ ¹ßÇö ºÐ¼®¿¡ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®Àº Á¾¾ç ÇÁ·ÎÆÄÀϸµ, Ä¡·á Àü·«, ¸é¿ª¿ä¹ý °³¹ß¿¡ µµ¿òÀÌ µË´Ï´Ù. ¸é¿ª ¹ÙÀÌ¿À¸¶Ä¿ÀÇ ¹ßÇöÀ» Æò°¡ÇÔÀ¸·Î½á, ¾Ï°ú ¸é¿ªÀÇ »óÈ£ÀÛ¿ë¿¡ °üÇÑ Áß¿äÇÑ Áö°ßÀ» ¾òÀ» ¼ö ÀÖ¾î Ç¥Àû Ä¡·áÀÇ ¹æÇ⼺ÀÌ ³ªÅ¸³³´Ï´Ù. ´Ü¹éÁúüÇÐ, À¯Àüü ºÐ¼® ¹× ¸ÖƼÇ÷º½º ±â¼ú°ú °°Àº ºÐ¾ßÀÇ °³¹ßÀº ³ôÀº 󸮷®ÀÇ ¸é¿ªÁ¾¾çÇÐ ºÐ¼®ÀÇ °³¹ßÀ» °¡´ÉÇϰÔÇß½À´Ï´Ù. ±âÁ¸ÀÇ Ç×Á¾¾ç ¸é¿ª ¹ÝÀÀÀ» ÃøÁ¤Çϰí Ä¡·á °á°ú¸¦ ¿¹ÃøÇÏ´Â ÀÌ·¯ÇÑ ´É·ÂÀº Á¤¹Ð Á¾¾çÇп¡¼­ ÇʼöÀûÀÎ µµ±¸°¡ µÇ¾ú½À´Ï´Ù.

½ÃÀå ¿ªÇÐ :

¼¼°èÀÇ ¸é¿ªÁ¾¾çÇÐ ºÐ¼® ½ÃÀåÀÇ ¼ºÀåÀº Ç¥Àû ¾Ï Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, º´¿ë ¸é¿ª ¿ä¹ýÀÇ Ã¤¿ë Áõ°¡, Á¦¾à ±â¾÷¿¡ ÀÇÇÑ R&D ÅõÀÚ Áõ°¡, µ¿¹ÝÁø´Ü °Ë»çÀÇ °¡¿ë¼º Çâ»ó µîÀÇ ¿äÀο¡ ÀÇÇØ °ßÀεǰí ÀÖ½À´Ï´Ù. ±×·¯³ª ¸é¿ªÁ¾¾çÇÐ °Ë»ç¿Í °ü·ÃµÈ °í¾×ÀÇ ºñ¿ë°ú ÀÌ·¯ÇÑ °Ë»ç¿¡ ´ëÇÑ »óȯÀÇ Á¦ÇÑ µî ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀεµ ÀÖ½À´Ï´Ù. ÇÑÆí, ¹ÙÀÌ¿À¸¶Ä¿ ¿¬±¸ÀÇ ÁøÇà°ú Àú·ÅÇÑ ¸é¿ªÁ¾¾çÇÐÀû °Ë»ç¹ýÀÇ °³¹ßÀº ½ÃÀå ÁøÃâÀÚ¿¡°Ô Å« ºñÁî´Ï½º ±âȸ°¡ µÇ°í ÀÖ½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦Á¶°Ç

Á¦2Àå ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

Á¦4Àå ¼¼°èÀÇ ¸é¿ªÁ¾¾çÇÐ ºÐ¼® ½ÃÀå - Äڷγª ¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ ¸é¿ªÁ¾¾çÇÐ ºÐ¼® ½ÃÀå, Á¦Ç°º°, 2020³â-2032³â,(10¾ï ´Þ·¯)

Á¦6Àå ¼¼°èÀÇ ¸é¿ªÁ¾¾çÇÐ ºÐ¼® ½ÃÀå, ±â¼úº°, 2020³â-2032³â,(10¾ï ´Þ·¯)

Á¦7Àå ¼¼°èÀÇ ¸é¿ªÁ¾¾çÇÐ ºÐ¼® ½ÃÀå, ÀûÀÀÁõº°, 2020³â-2032³â,(10¾ï ´Þ·¯)

Á¦8Àå ¼¼°èÀÇ ¸é¿ªÁ¾¾çÇÐ ºÐ¼® ½ÃÀå, ¿ëµµº°, 2020³â-2032³â,(10¾ï ´Þ·¯)

Á¦9Àå ¼¼°èÀÇ ¸é¿ªÁ¾¾çÇÐ ºÐ¼® ½ÃÀå, Áö¿ªº°, 2020³â-2032³â,(10¾ï ´Þ·¯)

Á¦10Àå °æÀï ±¸µµ

Á¦11Àå ºÐ¼®°¡ Ãßõ

Á¦12Àå Âü°í¹®Çå°ú Á¶»ç¹æ¹ý

SHW
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Immuno-Oncology Assays Market is estimated to be valued at USD 5.55 Bn in 2025 and is expected to reach USD 11.82 Bn by 2032, growing at a compound annual growth rate (CAGR) of 11.4% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 5.55 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 11.40% 2032 Value Projection: USD 11.82 Bn
Figure. Immuno-Oncology Assays Market Share (%), By Region 2025
Immuno-Oncology Assays Market - IMG1

Immuno-oncology assays help analyze the expression of biomolecules like proteins that are relevant for cancer immunotherapies. These assays aid in tumor profiling, treatment strategies, and development of immunotherapies. They help evaluate expression of immune biomarkers, which provides crucial insights into cancer-immune interactions and offers direction for targeted therapies. Advancements in fields like proteomics, genomic analysis, and multiplex technologies have enabled development of high-throughput immuno-oncology assays. Their ability to gauge pre-existing antitumor immune responses and predict treatment outcomes makes them integral tools in precision oncology.

Market Dynamics:

The global immuno-oncology assays market growth is driven by factors such as growing demand for targeted cancer therapies, rising adoption of combinational immunotherapies, increasing R&D investments by pharmaceutical companies, and improving availability of companion diagnostic tests. However, the market faces restraints in terms of high costs associated with immuno-oncology assays and limited reimbursement for such tests. Meanwhile, ongoing research on biomarkers and development of affordable immuno-oncology assays present significant opportunities for market players.

Key Features of the Study:

Detailed Segmentation-

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Immuno-Oncology Assays Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Immuno-Oncology Assays Market, By Product, 2020 - 2032, (USD Bn)

6. Global Immuno-Oncology Assays Market, By Technology, 2020 - 2032, (USD Bn)

7. Global Immuno-Oncology Assays Market, By Indication, 2020 - 2032, (USD Bn)

8. Global Immuno-Oncology Assays Market, By Application, 2020 - 2032, (USD Bn)

9. Global Immuno-Oncology Assays Market, By Region, 2020 - 2032, (USD Bn)

10. Competitive Landscape

11. Analyst Recommendation

12. References and Research Methodology

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â